These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7317557)

  • 21. Bayesian phylogeny analysis via stochastic approximation Monte Carlo.
    Cheon S; Liang F
    Mol Phylogenet Evol; 2009 Nov; 53(2):394-403. PubMed ID: 19589389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of histamine release assays using the Bootstrap.
    Coberly WA; Price JA
    J Immunol Methods; 2005 Jan; 296(1-2):103-14. PubMed ID: 15680155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of the influence of radionuclide biokinetics on the efficiency of in vivo counting using Monte Carlo simulation.
    Lamart S; Blanchardon E; Molokanov A; Kramer GH; Broggio D; Franck D
    Health Phys; 2009 May; 96(5):558-67. PubMed ID: 19359849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The estimation of relative potency from two parabolas in symmetric bioassays.
    Williams DA
    Biometrics; 1973 Dec; 29(4):695-700. PubMed ID: 4785234
    [No Abstract]   [Full Text] [Related]  

  • 25. [Shelf-life estimation of pharmaceutical products by matrixing].
    Yoshioka S; Aso Y; Kojima S
    Eisei Shikenjo Hokoku; 1996; (114):143-4. PubMed ID: 9037887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA.
    O'Hagan A; Stevenson M; Madan J
    Health Econ; 2007 Oct; 16(10):1009-23. PubMed ID: 17173339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing the efficiency of Monte Carlo cohort simulations with variance reduction techniques.
    Shechter SM; Schaefer AJ; Braithwaite RS; Roberts MS
    Med Decis Making; 2006; 26(5):550-3. PubMed ID: 16997930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monte Carlo simulations.
    Earl DJ; Deem MW
    Methods Mol Biol; 2008; 443():25-36. PubMed ID: 18446280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determining the error of dose estimates and minimum and maximum acceptable concentrations from assays with nonlinear dose-response curves.
    Gottschalk PG; Dunn JR
    Comput Methods Programs Biomed; 2005 Dec; 80(3):204-15. PubMed ID: 16256244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental verification of lung dose with radiochromic film: comparison with Monte Carlo simulations and commercially available treatment planning systems.
    Paelinck L; Reynaert N; Thierens H; De Neve W; De Wagter C
    Phys Med Biol; 2005 May; 50(9):2055-69. PubMed ID: 15843736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An EGS4 based Monte Carlo code for the calculation of organ equivalent dose to a modified Yale voxel phantom.
    Kramer R; Vieira JW; Lima FR; Fuelle D
    Cell Mol Biol (Noisy-le-grand); 2002 Jul; 48(5):465-73. PubMed ID: 12146699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of multivariate parallel-line bioassay with composite responses and composite doses, using canonical correlations.
    Yuan W; Kshirsagar AM
    J Biopharm Stat; 1993 Mar; 3(1):57-71. PubMed ID: 8485536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining multivariate bioassays.
    Meisner M; Kushner HB; Laska EM
    Biometrics; 1986 Jun; 42(2):421-7. PubMed ID: 3741980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A curve similarity approach to parallelism testing in bioassay.
    Faya P; Rauk AP; Griffiths KL; Parekh B
    J Biopharm Stat; 2020 Jul; 30(4):721-733. PubMed ID: 32163316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro--in vivo correlation, a time scaling problem? Basic techniques for testing equivalence.
    Brockmeier D; Voegele D; von Hattingberg HM
    Arzneimittelforschung; 1983; 33(4):598-601. PubMed ID: 6683542
    [No Abstract]   [Full Text] [Related]  

  • 36. Estimating relative potency using prior information.
    Kim PT; Carter EM; Hubert JJ
    Biometrics; 1991 Mar; 47(1):295-301. PubMed ID: 2049503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Monte Carlo comparison of three up-and-down designs for dose ranging.
    Bolognese JA
    Control Clin Trials; 1983 Sep; 4(3):187-96. PubMed ID: 6641232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Random drug excess.
    Helfenstein U; Steiner M
    Eur J Drug Metab Pharmacokinet; 1990; 15(4):309-15. PubMed ID: 2088767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Bayesian approach to bioassay.
    Ramsey FL
    Biometrics; 1972 Sep; 28(3):841-58. PubMed ID: 5073256
    [No Abstract]   [Full Text] [Related]  

  • 40. Equivalence testing for similarity in bioassays using bioequivalence criteria on the relative bioactivity.
    Baljé-Volkers C; Mzolo T; Talens E; IJzerman-Boon P; Van den Heuvel E
    Pharm Stat; 2018 Feb; 17(1):12-24. PubMed ID: 29110389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.